[The use of laser irradiation in nephrological practice]. 1994

S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin

The authors studied therapeutic potential and mechanism of action of low-intensity low-energy laser irradiating the skin at the site of the projection of the transplanted kidney poles through the development of chronic rejection or chronic pyelonephritis. The trial included 7 kidney recipients and 9 controls with primary chronic pyelonephritis. The treatment course implied 10 daily session of 20 minutes duration of He-Ne laser irradiation which was preceded by clinical-laboratory evaluation of the blood and urine, cellular and humoral immunity, hemostasis, central hemodynamics, local and mediator hormones, factors of nonspecific resistance, spin probe characteristics. The effect appeared contradictory. It is thought valid to combine quantum and drug therapy thus achieving optimal therapeutic effects and preventing side effects.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011704 Pyelonephritis Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA. Necrotizing Pyelonephritis,Pyelonephritis, Acute Necrotizing,Pyelonephritides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1979, Zhurnal eksperimental'noi i klinicheskoi meditsiny,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
May 1982, Vrachebnoe delo,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1992, Likars'ka sprava,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
November 1977, Sovetskaia meditsina,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
July 1972, Das Deutsche Gesundheitswesen,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1982, Terapevticheskii arkhiv,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1990, Terapevticheskii arkhiv,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
May 1995, Therapeutische Umschau. Revue therapeutique,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1982, Urologiia i nefrologiia,
S E Buglova, and V I Sokolakov, and V S Pilotovich, and N N Gomolko, and K A Chizh, and V A Vlasik, and V S Finin
January 1990, Sovetskaia meditsina,
Copied contents to your clipboard!